Skip to main content

Table 5 Univariate logistic regression results

From: High-sensitivity Troponin T in hemodialysis patients: a randomized placebo-controlled sub-study investigating angiotensin-II-blockade, variation over time and associations with clinical outcome

  

CV-events (0 vs. ≥1)

Admissions

(0 vs. ≥1)

IDH-episodes

(0 vs. ≥1)

TnT-peaks

(0 vs. ≥1)

 

n

OR (95% CI)

OR (95% CI)

OR (95% CI)

OR (95% CI)

Baseline TnT

 log (TnT)

81

2.25 (1.04–4.86)

2.62 (1.22–5.64)

1.87 (0.98–3.59)

0.94 (0.52–1.71)

 Low (TnT ≤ 45 ng/L) vs. High (TnT > 45 ng/L)

81

1.72 (0.58–5.09)

3.74 (1.29–10.86)

2.68 (1.05–6.79)

0.84 (0.35–2.03)

TnT change (Δ = 12 months-baseline)

 Δlog (TnT)

54

1.17 (0.20–6.93)

0.64 (0.14–2.91)

0.26 (0.04–1.56)

–

 Increase (ΔTnT> 0) vs. Decrease (ΔTnT≤0)

54

0.76 (0.19–3.01)

0.30 (0.08–1.10)

0.31 (0.10–0.96)

–

TnT amplitude (max-min)

 Low (TnT ≤ 20.5 ng/L) vs. High (TnT > 20.5 ng/L)

54

0.61 (0.15–2.46)

4.60 (1.24–16.97)

3.08 (0.97–9.67)

–

TnT-Peaks

 No peak vs. ≥1 peak

81

1.05 (0.51–2.15)

2.30 (1.00–5.30)

1.33 (0.73–2.44)

–

 Asprin (n = 37) vs. non-aspirin treatment (n = 44)

81

1.96 (0.66–5.80)

0.54 (0.20–1.44)

0.69 (0.28–1.73)

0.28 (0.11–0.72)

  1. Abbreviations: TnT Troponin T; TnT-peak 20% increase above individual TnT median value; CV Cardiovascular; IDH Intradialytic hypotensive episodes defined as symptomatic hypotension requiring administration of intravenous fluid or preterm ending of the dialysis session